S&P 500   4,604.92 (+0.01%)
DOW   36,327.73 (+0.22%)
QQQ   392.94 (+0.20%)
AAPL   191.81 (-1.99%)
MSFT   368.63 (-1.50%)
META   321.03 (-3.52%)
GOOGL   132.33 (-1.97%)
AMZN   144.88 (-1.72%)
TSLA   239.89 (-1.62%)
NVDA   460.18 (-3.13%)
NIO   7.44 (+0.81%)
BABA   71.37 (-1.07%)
AMD   132.03 (+2.41%)
T   16.74 (-1.06%)
F   11.09 (+0.73%)
MU   77.70 (+3.66%)
CGC   0.80 (-0.29%)
GE   120.17 (-0.35%)
DIS   92.66 (-0.17%)
AMC   6.82 (-1.59%)
PFE   28.56 (-0.76%)
PYPL   59.31 (+0.63%)
XOM   99.15 (-0.40%)
S&P 500   4,604.92 (+0.01%)
DOW   36,327.73 (+0.22%)
QQQ   392.94 (+0.20%)
AAPL   191.81 (-1.99%)
MSFT   368.63 (-1.50%)
META   321.03 (-3.52%)
GOOGL   132.33 (-1.97%)
AMZN   144.88 (-1.72%)
TSLA   239.89 (-1.62%)
NVDA   460.18 (-3.13%)
NIO   7.44 (+0.81%)
BABA   71.37 (-1.07%)
AMD   132.03 (+2.41%)
T   16.74 (-1.06%)
F   11.09 (+0.73%)
MU   77.70 (+3.66%)
CGC   0.80 (-0.29%)
GE   120.17 (-0.35%)
DIS   92.66 (-0.17%)
AMC   6.82 (-1.59%)
PFE   28.56 (-0.76%)
PYPL   59.31 (+0.63%)
XOM   99.15 (-0.40%)
S&P 500   4,604.92 (+0.01%)
DOW   36,327.73 (+0.22%)
QQQ   392.94 (+0.20%)
AAPL   191.81 (-1.99%)
MSFT   368.63 (-1.50%)
META   321.03 (-3.52%)
GOOGL   132.33 (-1.97%)
AMZN   144.88 (-1.72%)
TSLA   239.89 (-1.62%)
NVDA   460.18 (-3.13%)
NIO   7.44 (+0.81%)
BABA   71.37 (-1.07%)
AMD   132.03 (+2.41%)
T   16.74 (-1.06%)
F   11.09 (+0.73%)
MU   77.70 (+3.66%)
CGC   0.80 (-0.29%)
GE   120.17 (-0.35%)
DIS   92.66 (-0.17%)
AMC   6.82 (-1.59%)
PFE   28.56 (-0.76%)
PYPL   59.31 (+0.63%)
XOM   99.15 (-0.40%)
S&P 500   4,604.92 (+0.01%)
DOW   36,327.73 (+0.22%)
QQQ   392.94 (+0.20%)
AAPL   191.81 (-1.99%)
MSFT   368.63 (-1.50%)
META   321.03 (-3.52%)
GOOGL   132.33 (-1.97%)
AMZN   144.88 (-1.72%)
TSLA   239.89 (-1.62%)
NVDA   460.18 (-3.13%)
NIO   7.44 (+0.81%)
BABA   71.37 (-1.07%)
AMD   132.03 (+2.41%)
T   16.74 (-1.06%)
F   11.09 (+0.73%)
MU   77.70 (+3.66%)
CGC   0.80 (-0.29%)
GE   120.17 (-0.35%)
DIS   92.66 (-0.17%)
AMC   6.82 (-1.59%)
PFE   28.56 (-0.76%)
PYPL   59.31 (+0.63%)
XOM   99.15 (-0.40%)

Cerecor (CERC) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$0.05
$0.06
50-Day Range
$2.06
$3.24
52-Week Range
$1.98
$4.50
Volume
15.41 million shs
Average Volume
1.27 million shs
Market Capitalization
$5.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CERC stock logo

About Cerecor Stock (NASDAQ:CERC)

Cerecor, Inc. is a biopharmaceutical company, which engages in the development and commercialization of treatments for rare and orphan diseases. Its lead product candidates include CERC-801, CERC-802, and CERC-803, which are therapies for inherited metabolic disorders known as congenital disorders of glycosylation. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Rockville, MD.


CERC Stock News Headlines

mTOR Inhibitors Global Market Report 2023
All the trading advice you’ve ever received boils down to this
All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.
All the trading advice you’ve ever received boils down to this
All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.
See More Headlines
Receive CERC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cerecor and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/01/2021
Today
12/11/2023

Industry, Sector and Symbol

Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CERC
Fax
N/A
Employees
31
Year Founded
N/A

Profitability

Net Income
$-63,500,000.00
Net Margins
-1,194.82%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$6.70 million
Book Value
$0.22 per share

Miscellaneous

Free Float
N/A
Market Cap
$5.09 million
Optionable
Not Optionable
Beta
1.44
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Michael F. Cola
    Chairman & Chief Executive Officer
  • Schond L. Greenway
    Chief Financial Officer & Treasurer
  • H. Jeffrey Wilkins
    Chief Medical Officer
  • Garry Arthur NeilGarry Arthur Neil
    Chief Scientific Officer
  • Younok Dumortier Shin
    Chief Technology Officer














CERC Stock Analysis - Frequently Asked Questions

How were Cerecor's earnings last quarter?

Cerecor Inc. (NASDAQ:CERC) issued its quarterly earnings data on Sunday, August, 1st. The company reported ($0.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by $0.01. The business had revenue of $3.36 million for the quarter. Cerecor had a negative net margin of 1,194.82% and a negative trailing twelve-month return on equity of 261.82%.

What other stocks do shareholders of Cerecor own?
This page (NASDAQ:CERC) was last updated on 12/11/2023 by MarketBeat.com Staff

My Account -